Share
- Release Date: 18/07/12 15:50
- Summary: RELINT: RYM: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 2.6KB
RYM
18/07/2012 13:50
RELINT
REL: 1350 HRS Ryman Healthcare Limited
RELINT: RYM: Disclosure of Directors and Officers Relevant Interests
Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988
A Details of director or officer
Name of director or officer of public issuer: David William Kerr
Name of public issuer: Ryman Healthcare Ltd
Name of related body corporate (if applicable):
Position held in public issuer: Director
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 1) 27,500 Ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities: 2) Registered holder and
beneficial owner
Name of registered holder of those securities 3) David William Kerr
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 4) 16 July 2012
Consideration paid for acquisition: 5) $99,451 (or $3.6164 per share)
If the relevant interest was disposed of--
Date of disposal: 6) N/a
Consideration received for disposal: 7) N/a
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: 8) On market acquisition
E Total number of transactions this notice relates to: 9) One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10) 18 August 2011
G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Gordon MacLeod
Date of signature: 18 July 2012
Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary
Notes:
Use this form to disclose all the acquisitions and disposals by a director or
officer of a public issuer of relevant interests in securities of the public
issuer or of a related body corporate. The disclosure must normally be made
within 5 trading days of the first acquisition or disposal disclosed in this
notice
"Provide the information required under headings C and D for each type of
security identified under heading B."
"This notice must be signed either by the director or officer making the
disclosure, or by a person authorised by the director or officer to sign on
his or her behalf."
References
1. Regulation 8.
2. Regulation 7.
3. Regulation 7.
4. Regulation 9.
5. Regulation 10.
6. Regulation 9.
7. Regulation 10.
8. Regulation 11.
9. Regulation 12 (2)
10. Regulation 13.
11. Regulation 14.
End CA:00225071 For:RYM Type:RELINT Time:2012-07-18 13:50:40
